Loading...

Cogstate Limited

CGS.AXASX
Healthcare
Medical - Healthcare Information Services
A$1.74
A$0.01(0.58%)

Cogstate Limited (CGS.AX) Company Profile & Overview

Explore Cogstate Limited’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Cogstate Limited (CGS.AX) Company Profile & Overview

Cogstate Limited, a neuroscience technology company, provides computerized cognitive tests and electronic clinical outcome assessment solutions. The company's cognitive services include project management, data management, scientific consulting, statistical analysis, scales procurement, rater training, and monitoring solutions. It operates in Clinical Trials and Healthcare segments. The Clinical Trials segment provides technology and associated services that are used to quantify the effect of diseases and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. The Healthcare segment provides Cognigram, a system for regular and standardized testing to assist primary care physicians and/or hospitals in the early detection of cognitive decline. As of June 30, 2022, it had participated in approximately 1,800 academic research. Cogstate Limited was incorporated in 1999 and is based in Melbourne, Australia.

SectorHealthcare
IndustryMedical - Healthcare Information Services
CEOBradley John O'Connor CA

Contact Information

61 3 9664 1300
161 Collins Street, Melbourne, VIC, 3000

Company Facts

147 Employees
IPO DateFeb 12, 2004
CountryAU
Actively Trading

Frequently Asked Questions

;